食品伙伴网讯 据美国联邦公报消息,12月22日美国FDA发布条例,修订兽药条例,批准亚甲基水杨酸杆菌肽(bacitracin methylene disalicylate)作为兽药成分用于饲料。
本次修订申请由Pharmgate LLC公司提出。新条例批准含亚甲基水杨酸杆菌肽的A类药物性物品用于生产鸡、火鸡、野鸡、鹌鹑、肉牛B类与C类药物饲料。
部分原文报道如下:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmgate LLC for the use of a Type A medicated article containing bacitracin methylenedisalicylate to manufacture Type B and Type C medicated feeds for chickens, turkeys, pheasants, quail, and feedlot cattle. This supplemental approval reflects FDA's effectiveness conclusions that relied on the National Academy of Sciences/National Research Council Drug Efficacy Study Group's evaluation of the effectiveness of this drug as well indications for use not subject to this review.
本文由食品伙伴网编译,供网友参考,食品伙伴网提供欧盟、美国、英国、俄罗斯、日本、韩国、东南亚、西班牙等国家或地区的进出口合规咨询服务,欢迎垂询:0535-2129301,Email:vip@foodmate.net、news@foodmate.net.